Back to 
UBS Group AG
UBS Group AG
EFTR2 quarters
Position history for UBS Group AG's holdings in EFFECTOR THERAPEUTICS INC
No. Ubs exited its EFTR (Effector Therapeutics) position in Q3 2024. Its Q2 2024 13F listed 61,667 shares worth $17,883. Ubs first reported EFTR in Q2 2024 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$17,883
Total Shares Change
-61,667
Quarter-by-Quarter History
Other major holders of EFTR: Carlyle Group Inc., Ensign Peak Advisors, Inc, GEODE CAPITAL MANAGEMENT, LLC